Clinical presentation and diagnosis of primary HIV-1 infection

Current Opinion in HIV and AIDS

Volumn 3, Issue 1, 2008, Pages 10-15

  Daar, Eric S ^a   Pilcher, Christopher D ^b   Hecht, Frederick M ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clinical manifestations; Diagnosis; Primary HIV 1 infection

Indexed keywords

ANTIGEN P24; IMMUNOGLOBULIN M;

ARTHRALGIA; CERVICAL LYMPHADENOPATHY; CLINICAL FEATURE; DIAGNOSTIC TEST; DIARRHEA; DISEASE COURSE; ENZYME IMMUNOASSAY; FATIGUE; FEVER; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION PREVENTION; MYALGIA; NIGHT SWEAT; PHARYNGITIS; PRIORITY JOURNAL; RASH; REVIEW; SCREENING TEST; SEROCONVERSION; SYMPTOMATOLOGY; VIRUS DETECTION; VIRUS TRANSMISSION;

EID: 40349092792     PISSN: 1746630X     EISSN: 17466318     Source Type: Journal    
DOI: 10.1097/COH.0b013e3282f2e295     Document Type: Review

References (40)

1. Ho DD, Sarngadharan MG, Resnick L, et al. Primary human T-lymphotropic virus type III infection. Ann Intern Med 1985; 103:880-883.
2. Cooper DA, Gold J, MacLean P, et al. Acute AIDS retrovirus infection: definition of a clinical illness associated with seroconversion. Lancet 1985; 1985:537-540.
3. Daar ES, Little SJ, Pitt J, et al. Diagnosing primary HIV infection. Ann Intern Med 2001; 134:25-29.
4. Hecht FM, Busch MP, Rawal B, et al. Use of laboratory tests and clinical symptoms for identification of primary HIV infection. AIDS 2002; 24:1119-1129.
5. Tindall B, Barker S, Donovan B, et al. Characterization of the acute clinical illness associated with human immunodeficiency virus infection. Arch Intern Med 1988; 148:945-949.
6. Vanhems P, Dassa C, Lambert J, et al. Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection. J Acquir Immune Defic Syndr 1999; 21:99-106.
7. Vanhems P, Allard R, Cooper DA, et al. Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive. Clin Infect Dis 1997; 24:965-970.
8. Vanhems P, Routy JP, Hirschel B, et al. Clinical features of acute retroviral syndrome differ by route of infection but not by gender and age. J Acqu Immune Defic Syndr 2002; 31:318-321.
9. Schacker T, Collier AC, Hughes J, et al. Clinical and epidemiologic features of primary HIV infection. Ann Intern Med 1996; 125:257-264.
10. Gaines H, von Sydow M, Pehrson PO, Lundbergh P. Clinical picture of primary HIV infection presenting as glandular fever like illness. Br Med J 1988; 297:1362-1368.
11. Lavreys L, Baeten JM, Chohan V, et al. Higher set point plasma viral load and more-severe acute HIV type 1 (HIV-1) illness predict mortality among high-risk HIV-1-infected African women. Clin Infect Dis 2006; 42:1333-1339. This study is one of the best to systematically collect data on the relationship between clinical symptoms of primary infection and the natural history of disease.
12. Pedersen C, Lindhardt BO, Jensen BL, et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. Brit Med J 1989; 299:154-157.
13. Pedersen C, Katzenstein T, Nielsen C, et al. Prognostic value of serum HIV-RNA levels at virologic steady state after seroconversion: relation to CD4 cell count and clinical course of primary infection. J Acqu Immune Defic Syndr 1997; 16:93-99.
14. Vanhems P, Hirschel B, Phillips AN, et al. Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS. J Infect Dis 2000; 182:334-337.
15. Vanhems P, Voirin N, Hirschel B, et al. Brief report: incubation and duration of specific symptoms at acute retroviral syndrome as independent predictors of progression to AIDS. J Acqu Immune Defic Syndr 2003; 32:542-544.
16. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995; 122:573-579.
17. Kaufmann GR, Cunningham P, Zaunders J, et al. Impact of early HIV-1 RNA and T-lymphocyte dynamics during primary HIV-1 infection on the subsequent course of HIV-1 RNA levels and CD4+ T-lymphocyte counts in the first year of HIV-1 infection. J Acqu Immune Defic Syndr 1999; 22:437-444.
18. 6/L, AIDS, and death from AIDS? BMJ 1994; 309:1535-1537.
19. Keet IP, Krijnen P, Koot M, et al. Predictors of rapid progression to AIDS in HIV-1 seroconverters. AIDS 1993; 7:51-57.
20. Vanhems P, Lambert J, Cooper DA, et al. Severity and prognosis of acute human immunodeficiency virus type 1 illness: A dose-response relationship. Clin Infect Dis 1998; 26:323-329.
21. Lavreys L, Baeten JM, Overbaugh J, et al. Virus load during primary Human Immunodeficiency Virus (HIV) type 1 infection is related to the severity of acute HIV illness in Kenyan women. Clin Infect Dis 2002; 35:77-81.
22. Kelley CF, Barbour JD, Hecht FM. The relation between symptoms, viral load, and viral load set point in primary HIV infection. J Acqu Immune Defic Syndr 2007; 45:445-448. This study is one of the largest to show that the number of symptoms present at the time of primary infection was statistically associated with viral set point.
23. Lindbäck S, Thorstensson R, Karlsson AC, et al. Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group. AIDS 2000; 14:2333-2339.
24. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191:1403-1409.
25. Hecht FM, Wang L, Collier A, et al. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis 2006; 194:725-733.
26. Clark SJ, Kelen GD, Henrard DR, et al. Unsuspected primary HIV-1 infection in seronegative emergency department patients. J Infect Dis 1994; 170:194-197.
27. Pincus JM, Crosby SS, Losina E, et al. Acute human immunodeficiency virus infection in patients presenting to an urban urgent care center. Clin Infect Dis 2003; 37:1699-1704.
28. Pilcher CD, Price MA, Hoffman IF, et al. Frequent detection of acute primary HIV infection in men in Malawi. AIDS 2004; 18:517-524.
29. Fiscus SA, Pilcher CD, Miller WC, et al. Rapid, real-time detection of acute HIV infection in patients in Africa. J Infect Dis 2007; 195:416-424. Demonstrated the ability to use real-time pooled testing in a resource limited setting to identify primary HIV-1 infection.
30. Bollinger RC, Brookmeyer RS, Mehendale SM, et al. Risk factors and clinical presentation of acute primary HIV infection in India. JAMA 1997; 278:2085-2089.
31. Quinn TC, Brookmeyer R, Kline R, et al. Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence. AIDS 2000; 14:2751-2757.
32. Pilcher CD, Fiscus SA, Nguyen TQ, et al. Detection of acute infections during HIV testing in North Carolina. N Engl J Med 2005; 352:1873-1883.
33. Priddy FH, Pilcher CD, Moore RH, et al. Detection of acute HIV infections in an urban HIV counseling and testing population in the United States. J Acqu Immune Defic Syndr 2007; 44:196-202. This study demonstrated how NAAT can enhance identification of HIV infection in a urban HIV testing and counseling center.
34. Patel P, Klausner JD, Bacon OM, et al. Detection of acute HIV infections in high-risk patients in California. J Acqu Immune Defic Syndr 2006; 42:75-79.
35. Stekler J, Swenson PD, Wood RW, et al. Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with men. AIDS 2005; 19:1323-1325.
36. Kim HY, Hudgens MG, Dreyfuss JM, et al. Comparison of group testing algorithms for case identification in the presence of test error. Biometrics 2007 May 14 [ePub ahead of print].
37. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR 2006; 55:1-17.
38. Powers KA, Miller WC, Pilcher CD, et al. Improved detection of acute HIV-1 infection in sub-Saharan Africa: Development of a risk score algorithm. AIDS 2007 [in press].
39. Ly TD, Ebel A, Faucher V, et al. Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays? J Virol Methods 2007; 143:86-94. A thorough assessment of the performance of current fourth generation EIA assays for HIV infection.
40. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003; 17:1871-1879.